Injection site and risk of medically attended local reactions to acellular pertussis vaccine
- PMID: 21300679
- DOI: 10.1542/peds.2010-1886
Injection site and risk of medically attended local reactions to acellular pertussis vaccine
Abstract
Objective: To assess whether the risk of medically attended local reactions to the fifth dose of the diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine varies according to injection site (arm versus thigh).
Methods: We conducted a retrospective cohort study of children aged 4 through 6 years in the Vaccine Safety Datalink population who received a DTaP vaccination during the period from 2002 through 2006. Medically attended local reactions to the DTaP vaccine were presumptively identified from administrative data and were confirmed by medical record review.
Results: Among the 233,616 children in the study population, 1017 (0.4%) had a confirmed medically attended local reaction to the fifth dose of the DTaP vaccine. The rate of those reactions was significantly higher with vaccinations given in the arm (47.4 per 10,000 vaccinations) compared with vaccinations given in the thigh (32.1 per 10,000 vaccinations) (P < .001). In a multivariable analysis adjusted for age, gender, and study site, children vaccinated in the arm had a 78% higher risk of a local reaction (relative risk: 1.78 [95% confidence interval: 1.43-2.21]).
Conclusions: Local reactions to the fifth dose of the DTaP vaccine that require medical evaluation are uncommon, but the risk of those reactions is significantly higher when the vaccine is injected in the arm. These findings suggest that the thigh should be considered as an acceptable site of injection for this vaccination.
Similar articles
-
New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel).Ann Pharmacother. 2010 Mar;44(3):515-23. doi: 10.1345/aph.1M468. Ann Pharmacother. 2010. PMID: 20197476 Review.
-
Prospective assessment of the effect of needle length and injection site on the risk of local reactions to the fifth diphtheria-tetanus-acellular pertussis vaccination.Pediatrics. 2008 Mar;121(3):e646-52. doi: 10.1542/peds.2007-1653. Pediatrics. 2008. PMID: 18310184
-
Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.J Pediatr. 2006 Nov;149(5):603-610. doi: 10.1016/j.jpeds.2006.06.016. J Pediatr. 2006. PMID: 17095328 Clinical Trial.
-
An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.Vaccine. 2007 Jan 22;25(6):1121-5. doi: 10.1016/j.vaccine.2006.09.053. Epub 2006 Oct 2. Vaccine. 2007. PMID: 17045366 Clinical Trial.
-
The diphtheria and pertussis components of diphtheria-tetanus toxoids-pertussis vaccine should be genetically inactivated mutant toxins.J Infect Dis. 2005 Jan 1;191(1):81-8. doi: 10.1086/426454. Epub 2004 Nov 30. J Infect Dis. 2005. PMID: 15593007 Review.
Cited by
-
Vaccinology Education of Nurses and the Current Immunoprophylaxis Recommendations for Children with Juvenile Idiopathic Arthritis.J Clin Med. 2020 Nov 20;9(11):3736. doi: 10.3390/jcm9113736. J Clin Med. 2020. PMID: 33233818 Free PMC article. Review.
-
Patterns of local site reactions to subcutaneous glatiramer acetate treatment of multiple sclerosis: a clinicopathological study.Int J Clin Exp Pathol. 2018 Jun 1;11(6):3126-3133. eCollection 2018. Int J Clin Exp Pathol. 2018. PMID: 31938441 Free PMC article.
-
The use of natural language processing to identify Tdap-related local reactions at five health care systems in the Vaccine Safety Datalink.Int J Med Inform. 2019 Jul;127:27-34. doi: 10.1016/j.ijmedinf.2019.04.009. Epub 2019 Apr 13. Int J Med Inform. 2019. PMID: 31128829 Free PMC article.
-
Effect of alcohol skin cleansing on vaccination-associated infections and local skin reactions: a randomized controlled trial.Hum Vaccin Immunother. 2019;15(4):995-1002. doi: 10.1080/21645515.2018.1553474. Epub 2019 Jan 16. Hum Vaccin Immunother. 2019. PMID: 30513266 Free PMC article. Clinical Trial.
-
Safety Surveillance of Diphtheria and Tetanus Toxoids and Acellular Pertussis (DTaP) Vaccines.Pediatrics. 2018 Jul;142(1):e20174171. doi: 10.1542/peds.2017-4171. Epub 2018 Jun 4. Pediatrics. 2018. PMID: 29866795 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical